| Sarcomas and DDR-Inhibition; a Combined Modality Study (NCT05116254) | The Netherlands Cancer Institute | 2022-07-18 |
| Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas (NCT05182164) | Institut Bergonié | 2022-04-25 |
| Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumors (NCT05352750) | Sonnet BioTherapeutics | 2022-04-20 |
| Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients (NCT07432932) | Royal Marsden NHS Foundation Trust | 2021-11-19 |
| Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients (NCT05961761) | Niels Junker | 2021-08-17 |
| Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma (NCT04577014) | Memorial Sloan Kettering Cancer Center | 2020-09-29 |
| Pre-operative RadiothErapy for Soft Tissue SarcOmas (NCT04617327) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2020-06-05 |
| Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study (NCT04095208) | Institut Bergonié | 2020-02-27 |
| Combined Treatment of Patients With Soft Tissue Sarcoma Including Preoperative Stereotactic Radiation Therapy and Postoperative Conformal Radiation Therapy (NCT04330456) | N.N. Petrov National Medical Research Center of Oncology | 2020-02-01 |
| Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients (NCT04008238) | Institut Bergonié | 2020-01-06 |
| Efficacy and Safety of Anlotinib in Adjuvant Therapy for High-grade Soft Tissue Sarcoma (NCT03951571) | Fudan University | 2019-05-13 |
| Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or Pazopanib (NCT03735758) | GWT-TUD GmbH | 2018-11-02 |
| Low Dose Continuous Cyclophosphamide vs Standard Doxorubicin in Advanced Sarcoma Elderly Patients (NCT04656262) | Istituto Oncologico Veneto IRCCS | 2018-09-10 |
| Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma (NCT03526679) | National Taiwan University Hospital | 2018-07-12 |
| Impact of Locoregional Treatment of Soft Tissue Sarcoma on Status of Patients Aged 70 Years and Over (NCT03077178) | Institut Bergonié | 2017-11-30 |
| Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma (NCT03056001) | Wake Forest University Health Sciences | 2017-05-01 |
| Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter Trial (NCT03104335) | Peking University People's Hospital | 2017-04-01 |
| Radiation Effects on Bone (NCT03134742) | State University of New York - Upstate Medical University | 2017-03-13 |
| Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma (NCT03056599) | Presage Biosciences | 2016-12-15 |
| A Study of IMRT in Primary Bone and Soft Tissue Sarcoma (NCT02520128) | University College, London | 2016-03-01 |